-

FBRT Investor Alert: FRANKLIN BSP REALTY TRUST, INC. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealed Material Risks: Levi & Korsinsky

Disclosure Under Scrutiny: Were Risk Warnings Adequate at Franklin BSP Realty Trust?

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP examines the adequacy of Franklin BSP Realty Trust, Inc.'s (NYSE: FBRT) risk disclosures during the period November 5, 2024 through February 11, 2026. Shareholders who lost money on FBRT may find out if you are eligible to pursue a recovery claim or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

FBRT shares fell $1.44, or 14.18%, to close at $8.71 on February 12, 2026, after the Company slashed its quarterly dividend from $0.355 to $0.20 per share. The lead plaintiff deadline is April 27, 2026.

What the Company Disclosed

Throughout the Class Period, FBRT's earnings calls contained forward-looking statements about dividend sustainability. Management repeatedly stated the $0.355 quarterly payout "accurately reflects our portfolio's long-term stabilized earnings potential." SEC filings contained standard risk factor language acknowledging that distributions could exceed earnings. Yet on every quarterly call from Q3 2024 through Q3 2025, executives affirmed confidence in the dividend level and laid out specific dollar-per-share roadmaps to reach coverage.

What the Complaint Challenges as Missing

The securities action contends that boilerplate risk factors were inadequate given what management allegedly knew. Specifically, the complaint charges that while generic language warned distributions "may" exceed taxable income, executives simultaneously made affirmative representations that contradicted those warnings:

- Management described the earnings shortfall as "entirely an REO conversation" while REO liquidations were allegedly taking far longer than planned

- The Company outlined three specific drivers totaling $0.20 to $0.26 per share in incremental quarterly earnings, yet distributable earnings remained at $0.27 against a $0.355 dividend for multiple quarters

- Executives stated they "could not be more confident in the earnings power of the platform" while GAAP EPS declined from $0.29 to $0.13 quarter over quarter (Q4 2024 vs. Q4 2025)

- The Board maintained the $0.355 dividend for at least five consecutive quarters despite never achieving coverage

Why Generic Warnings May Not Protect

Under federal securities law, a company cannot insulate itself from liability by burying generic risk factors in filings while its officers make specific, affirmative statements on earnings calls that paint a materially different picture. The complaint alleges that FBRT's disclosures created a misleading total mix of information: cautious boilerplate in one document, aggressive confidence on the conference call.

"Generic risk factor language cannot substitute for disclosing specific, known problems that are already affecting a company's operations. When officers make repeated affirmative statements about dividend sustainability while distributable earnings consistently fall short, the adequacy of the company's disclosures comes into serious question." -- Joseph E. Levi, Esq.

Evaluate whether you qualify to recover losses in the FBRT securities action or call Joseph E. Levi, Esq. at (212) 363-7500.

LEAD PLAINTIFF DEADLINE: April 27, 2026

Levi & Korsinsky, LLP, Top 50 securities litigation firm (ISS, seven consecutive years). Over 70 professionals. Hundreds of millions recovered for investors.

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

Levi & Korsinsky, LLP

NYSE:FBRT

Release Versions

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

More News From Levi & Korsinsky, LLP

GIL Investor Alert: Levi & Korsinsky Investigates Gildan Activewear (GIL) for Potential Securities Fraud

NEW YORK--(BUSINESS WIRE)--Shareholders who held Gildan Activewear (NYSE: GIL) lost nearly 19% of their investment value today after Jehoshaphat Research published allegations that Gildan had been stuffing distributor channels with approximately $510 million in excess inventory, a condition never referenced in the Company's forward guidance or outlook statements. Those who lost money on GIL are encouraged to submit their information to Levi & Korsinsky. You may also contact Joseph E. Levi,...

NNOX Shareholder Alert: Nano-X Imaging Ltd. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP highlights the contrast between Nano-X Imaging Ltd.'s (NASDAQ: NNOX) public commitments and its actual results. A securities class action has been filed on behalf of investors who purchased NNOX securities between March 31, 2025 and April 17, 2026. Find out if you can recover your investment losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.Nano-X told shareholders it was building a "highly efficient and scala...

NMRA Investor Alert: Levi & Korsinsky Investigates Neumora Therapeutics (NMRA) for Potential Securities Fraud

NEW YORK--(BUSINESS WIRE)--Neumora Therapeutics (NASDAQ: NMRA) shareholders watched their investment collapse today after the company disclosed that navacaprant failed both Phase 3 KOASTAL-2 and KOASTAL-3 trials in major depressive disorder and announced an immediate workforce reduction of approximately 35%. Investors who lost money on NMRA are encouraged to submit their information now to discuss their legal rights. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com...
Back to Newsroom